PMAM
UTHR icon

Picton Mahoney Asset Management’s United Therapeutics UTHR Stock Holding History

Picton Mahoney Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3
Closed -$1.78K – 1658
2026
Q1 		$1.78K Hold
3
– – ﹤0.01% 1040
2025
Q4 		$1.46K Hold
3
– – ﹤0.01% 1011
2025
Q3 		$1K Hold
3
– – ﹤0.01% 1039
2025
Q2 		$1K Hold
3
– – ﹤0.01% 941
2025
Q1 		$1K Hold
3
– – ﹤0.01% 903
2024
Q4 		$1K Hold
3
– – ﹤0.01% 824
2024
Q3 		$1K Buy
+3
New +$1.01K ﹤0.01% 811
2014
Q2 		– Sell
-1,000
Closed -$94K – 355
2014
Q1 		$94K Hold
1,000
– – 0.01% 316
2013
Q4 		$113K Sell
1,000
-300
-23% -$27.1K 0.01% 303
2013
Q3 		$103K Buy
+1,300
New +$95K 0.01% 290

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Picton Mahoney Asset Management's UTHR Position: Q2 2026 in Review

Picton Mahoney Asset Management sold out of United Therapeutics (UTHR) in Q2 2026, closing a stake of 3 shares — an estimated $1.78K sold.

Picton Mahoney Asset Management first reported a position in UTHR in Q3 2013 and held it in 10 quarters. The position peaked at $113K in Q4 2013. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Picton Mahoney Asset Management reported no remaining United Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 3 United Therapeutics shares in Q2 2026, an estimated $1.78K.
  • Picton Mahoney Asset Management first reported a position in United Therapeutics in Q3 2013 and held it in 10 quarters.
  • Picton Mahoney Asset Management's United Therapeutics position peaked at $113K in Q4 2013.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.